Format
Sort by

Send to

Choose Destination

Search results

Items: 19

1.

A low-cost, tablet-based option for prehospital neurologic assessment: The iTREAT Study.

Chapman Smith SN, Govindarajan P, Padrick MM, Lippman JM, McMurry TL, Resler BL, Keenan K, Gunnell BS, Mehndiratta P, Chee CY, Cahill EA, Dietiker C, Cattell-Gordon DC, Smith WS, Perina DG, Solenski NJ, Worrall BB, Southerland AM; As the iTREAT Investigators.

Neurology. 2016 Jul 5;87(1):19-26. doi: 10.1212/WNL.0000000000002799. Epub 2016 Jun 8.

PMID:
27281534
2.

An overview of antithrombotics in ischemic stroke.

Schweickert PA, Gaughen JR, Kreitel EM, Shephard TJ, Solenski NJ, Jensen ME.

Nurse Pract. 2016 Jun 19;41(6):48-55. doi: 10.1097/01.NPR.0000483077.47966.6e.

PMID:
27153001
3.

Mobile Telestroke During Ambulance Transport Is Feasible in a Rural EMS Setting: The iTREAT Study.

Lippman JM, Smith SN, McMurry TL, Sutton ZG, Gunnell BS, Cote J, Perina DG, Cattell-Gordon DC, Rheuban KS, Solenski NJ, Worrall BB, Southerland AM.

Telemed J E Health. 2016 Jun;22(6):507-13. doi: 10.1089/tmj.2015.0155. Epub 2015 Nov 24.

PMID:
26600433
4.

Addressing Disparities in Stroke Prevention for Atrial Fibrillation: Educational Opportunities.

Karcher R, Berman AE, Gross H, Hess DC, Jauch EC, Viser PE, Solenski NJ, Wolf AM.

Am J Med Qual. 2016 Jul;31(4):337-48. doi: 10.1177/1062860615577971. Epub 2015 Mar 18.

PMID:
25788477
5.

The TeleStroke mimic (TM)-score: a prediction rule for identifying stroke mimics evaluated in a Telestroke Network.

Ali SF, Viswanathan A, Singhal AB, Rost NS, Forducey PG, Davis LW, Schindler J, Likosky W, Schlegel S, Solenski N, Schwamm LH; Partners Telestroke Network.

J Am Heart Assoc. 2014 Jun 23;3(3):e000838. doi: 10.1161/JAHA.114.000838.

6.

Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators.

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.

7.

Telehealth stroke education for rural elderly Virginians.

Schweickert PA, Rutledge CM, Cattell-Gordon DC, Solenski NJ, Jensen ME, Branson S, Gaughen JR.

Telemed J E Health. 2011 Dec;17(10):784-8. doi: 10.1089/tmj.2011.0080. Epub 2011 Oct 19.

PMID:
22011051
8.

Overlapping features of eclampsia and postpartum angiopathy.

Fletcher JJ, Kramer AH, Bleck TP, Solenski NJ.

Neurocrit Care. 2009;11(2):199-209. doi: 10.1007/s12028-009-9221-0. Epub 2009 Apr 29.

PMID:
19404782
9.

R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS.

Wang H, Larriviere KS, Keller KE, Ware KA, Burns TM, Conaway MA, Lacomis D, Pattee GL, Phillips LH 2nd, Solenski NJ, Zivkovic SA, Bennett JP Jr.

Amyotroph Lateral Scler. 2008 Feb;9(1):50-8. doi: 10.1080/17482960701791234.

PMID:
18270879
10.

Emerging risk factors for cerebrovascular disease.

Solenski NJ.

Curr Drug Targets. 2007 Jul;8(7):802-16. Review.

PMID:
17630933
11.

The adenosine 2A receptor agonist ATL-146e attenuates experimental posthemorrhagic vasospasm.

Chang CZ, Dumont AS, Simsek S, Titus BJ, Kwan AL, Kassell NF, Solenski NJ.

Neurosurgery. 2007 Jun;60(6):1110-7; discussion 1117-8.

PMID:
17538386
12.

Nitric oxide impairs mitochondrial movement in cortical neurons during hypoxia.

Zanelli SA, Trimmer PA, Solenski NJ.

J Neurochem. 2006 May;97(3):724-36. Epub 2006 Apr 5.

13.

Mechanisms of ischemic neuroprotection by acetyl-L-carnitine.

Zanelli SA, Solenski NJ, Rosenthal RE, Fiskum G.

Ann N Y Acad Sci. 2005 Aug;1053:153-61. Review.

14.

Transient ischemic attacks: Part II. Treatment.

Solenski NJ.

Am Fam Physician. 2004 Apr 1;69(7):1681-8. Review.

15.

Information from your family doctor. Strokes and TIAs.

Solenski NJ; American Academy of Family Physicians.

Am Fam Physician. 2004 Apr 1;69(7):1679-80. No abstract available.

16.

Transient ischemic attacks: Part I. Diagnosis and evaluation.

Solenski NJ.

Am Fam Physician. 2004 Apr 1;69(7):1665-74. Review. Erratum in: Am Fam Physician. 2006 Mar 15;73(6):974.

17.

Nitric-oxide-induced depolarization of neuronal mitochondria: implications for neuronal cell death.

Solenski NJ, Kostecki VK, Dovey S, Periasamy A.

Mol Cell Neurosci. 2003 Dec;24(4):1151-69.

PMID:
14697675
18.

Neurotoxic nitric oxide rapidly depolarizes and permeabilizes mitochondria by dynamically opening the mitochondrial transition pore.

Kindler DD, Thiffault C, Solenski NJ, Dennis J, Kostecki V, Jenkins R, Keeney PM, Bennett JP Jr.

Mol Cell Neurosci. 2003 Aug;23(4):559-73.

PMID:
12932437
19.

Ultrastructural changes of neuronal mitochondria after transient and permanent cerebral ischemia.

Solenski NJ, diPierro CG, Trimmer PA, Kwan AL, Helm GA.

Stroke. 2002 Mar;33(3):816-24. Erratum in: Stroke 2002 Apr;33(4):1171. Helms Gregory A [corrected to Helm Gregory A].

Items per page

Supplemental Content

Loading ...
Write to the Help Desk